ImpediMed Limited announced the appointment of Richard Valencia as Chief Executive Officer of the Company, effective 1 December 2022. Mr. Valencia brings 30 years of leadership in the healthcare and technology industry sectors. He has focused on building cohesive management teams to implement change in the delivery of services to a broad customer base in the areas of connectivity of medical monitoring devices and solutions to improve electronic health record applications via digital health and cloud-based SaaS platforms. Previously, Mr. Valencia was interim Chairman & CEO of WaveForm Diabetes.

Prior to this, Mr. Valencia was a Board member at Tandem Diabetes Care, which experienced an increase in market capitalisation from USD 250 million to USD 5 billion during Mr. Valencia's tenure. Prior to Tandem, Mr. Valencia was Senior Vice President at Qualcomm Incorporated and President of Qualcomm Life, where he led a team focused on client relationships at over 2,500 hospitals globally and numerous top pharmaceutical, medical device and health insurance companies. He also founded and provided oversight to Qualcomm's digital health venture fund and the digital therapeutics venture fund in partnership with Novartis.

He has successfully led the launch of FDA listed cloud-based SaaS platforms for remote care and vital sign monitoring in ambulatory care settings. Mr. Valencia has also played an active role in founding, financing and growing numerous other businesses. Current Interim CEO and Board member, David Anderson, will continue to support the company upon Mr. Valencia's appointment.

Mr. Anderson's history in the healthcare and insurance industries and expertise working with insurance reimbursement programs has provided, and will continue to provide, strength for it's reimbursement strategy and long-term success. Mr. Valencia holds Bachelor of Science in Finance from California State University. He is the Chairman of CareAlign, a board member of Luminia and Co-Vice Chair of CONNECT.